June 6, 2017 5:52pm

 

The question is not whether investors should continue fearful, especially in a sector that has so many hot spots seemingly about to burst into flames, but understanding …

It ain’t over till it’s over, the late, great political philosopher Yogi Berra used to say. And this one sure ain’t over!

 

Pre-open indications re-cap: 10 HITS and 1 MISS

 

As I had stated, “Pricing has been percolating on the low end of the spectrum. Most of the RegMed, cell therapy equities are way below I-Bank target and they still haven’t been readjusted.”

 

I answer one question, in which company should investors commit and keep their money.

 

Lose an advantage or be a subscriber!  Today’s results have implications to Wednesday's sector activity.  

 

 

A daily report may say little or a lot and its final judgement may be inconclusive; yet it serves as insurance that all indications are being examined and evaluated.

 

 

Henry’omics:

From the pre-open’s investor’s newsletter … “the Sirens are singing … Some of the oversold are uttering an appeal while overbought are being lured to the rocks.”

Reiterating, “Like Odysseus, I’m confident I can listen to the Sirens and continue to write about it.”

 

The sector and markets are signaling apprehension among traders.

I believe investors, are sitting on the sidelines as the sector and market have been flat alternating in the past few days as it waits for some clarity.

 

My question is what … constitutes … clarity these days as we suffer the lack of headlines, fake news and those companies who willfully fail to disclose …

And I do add those who fail to disclose will and have become … cannon fodder for the future!  Think Uber …

I can almost hear Paul Simon in the background: “Slip slidin’ away, slip slidin’ away, you know the nearer your destination the more you’re slip slidin’ away.”

 

 

Pre-open indications re-cap:  10 hits and 1 miss …

  • Aduro Biotech (ADRO) closed down -$0.25 – hit;
  • Applied Genetic Technologies (AGTC) closed up +$0.03 – hit;
  • Athersys (ATHX) closed down -$0.02 – hit;
  • Bellicum Pharmaceutics (BLCM) closed up +$0.07 – hit;
  • bluebird bio (BLUE) closed up +$6.90 – hit;
  • Cytori (CYTX) closed down -$0.04 – miss;
  • Juno Therapeutics (JUNO) closed up +$0.81 – hit;
  • Kite Therapeutics (KITE) closed up +$3.03 – hit;
  • Sangamo Therapeutics (SGMO) closed flat at $7.20 – hit;
  • Stemline (STML) closed down -$0.05 – hit;
  • Verastem (VSTM) closed up +$0.02 – hit;

 

 

Daily analytics:

U.S. equities closed DOWN on Tuesday … with the DOW closing DOWN -0.21% (-45.00) as the NASDAQ also closed DOWN -0.33% (-20.63) …

… The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, traded near 10.5 …

· Monday traded near 9.8 following Friday’s near 9.8 following Thursday’s  below 10, Wednesday’s near 10.8 and last Tuesday’s near 10.2,

 

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated a negative -0.53% at the pre-open and closed

·         Tuesday traded DOWN -0.09%

·         Monday -0.55%

·         Friday +0.65%,

·         Thursday +1.93%,

·         Wednesday -0.10%

·         Last Tuesday -0.77%

… The iShares NASDAQ Biotechnology (IBB) did NOT indicated in the pre-open and closed

·         Tuesday traded DOWN -0.46%

·         Monday -0.62%

·         Friday +1.68%

·         Thursday +1.80% …

·         Wednesday  +0.51%

·         Last Tuesday  -1.36%

 

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The open was negative with an A/DL of 11/26 and 6 flats;

·         The mid-day was negative with an A/DL of 14/25 and 4 flats;

·         The close was negative with an A/DL of 18/19 and 6  flats;

 

 

The count - decliners versus gainers:

……. look at the differences in the spreads ……….

·         Tuesday’s decliners ranged from -0.37% <ONCE> to -6.98% <NWBO> in 19 equities;

·         Monday’s decliners ranged from -0.16% <CLLS> to -10.74% <JUNO> in 30 equities;

·         Friday’s decliners ranged from -0.33% <ONCE> to -3.85% <ISCO> in 11 equities;

·         Thursday’s decliners ranged from -0.18% <QURE> to -3.17% <VTGN> in 10 equities;

·         Wednesday’s decliners ranged from -0.08% <KITE> to -15.24% <NWBO> in 24 equities;

·         Last Tuesday’s decliners ranged from -0.37% <XON> to -7.22% <RGNX> in 29 equities;

Versus

·         Tuesday’s gainers ranged from +0.12%  <CLLS> to +7.56% <BLUE> in 18 equities;

·         Monday’s gainers ranged from +0.68% (+$0.01) <ATHX> to +8.50% <BLUE> in 10 equities;

·         Friday’s gainers ranged from +0.46% <VSTM> to +6.98% <JUNO> in 31 equities;

·         Thursday’s gainers ranged from +0.66% <MDXG> to +18.18% <ISCO> in 29 equities;

·         Wednesday’s gainers ranged from +0.18% <QURE> to +4.94% <CUR> in 14 equities;

·         Last Tuesday’s gainers ranged from +0.04% <CLLS> to +14.86% <NWBO> in 10 equities;

 

 

Some of MY working trend lines or indications for tomorrow:

… The greatest volume to the downside:  RENE.L, ONVO, MDXG and CYTX

… Upside volume was weighted to: BLUE, JUNO, XON, BLCM and BTX

… Biggest $ downside:  NWBO, OSIR, CYTX, ONVO and QURE

… Largest $ upside: BLUE, KITE, JUNO, XON and MESO

… Flats:  ADVM, PSTI, RENE.L, ISCO, VTGN and SGMO

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.